Skip to main navigation
Skip to search
Skip to main content
Sefako Makgatho Health Sciences University Home
Search content at Sefako Makgatho Health Sciences University
Home
Profiles
Departments
Research output
Activities
Rifaximin in non-alcoholic steatohepatitis: An open-label pilot study
Jeremy F.L. Cobbold
*
, Stephen Atkinson
, Julian R. Marchesi
, Ann Smith
, Sann N. Wai
, Julie Stove
, Fariba Shojaee-Moradie
, Nicola Jackson
, A. Margot Umpleby
, Julie Fitzpatrick
,
E. Louise Thomas
, Jimmy D. Bell
, Elaine Holmes
, Simon D. Taylor-Robinson
, Robert D. Goldin
, Michael S. Yee
, Quentin M. Anstee
, Mark R. Thursz
*
Corresponding author for this work
Research output
:
Contribution to journal
›
Article
›
peer-review
47
Citations (Scopus)
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Rifaximin in non-alcoholic steatohepatitis: An open-label pilot study'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Alanine Aminotransferase
28%
Beneficial Effects
14%
Biopsy-proven
14%
Diabetes
28%
Downstream Effects
14%
Elevated Aminotransferases
14%
Fecal Microbiota
14%
Glucose Uptake
14%
Gut Dysbiosis
14%
Gut Microbiota Modulation
14%
Hepatic Inflammation
14%
Hepatic Insulin Sensitivity
28%
Hepatic Lipid
28%
Hippurate
14%
Homeostatic Model
14%
Hyperinsulinemic-euglycemic Clamp
14%
Insulin Resistance Index
14%
Insulin Sensitivity
14%
Lipid Content
28%
Median Range
14%
Metabolic Profiling
14%
Nonalcoholic Steatohepatitis
100%
Observation Period
14%
Oral Hypoglycemic Agents
14%
Peripheral Insulin Sensitivity
14%
Relative Abundance
14%
Rifaximin
100%
Serum Alanine Aminotransferase
14%
Steatosis
14%
Twice Daily
14%
Medicine and Dentistry
Alanine Aminotransferase
42%
Antidiabetic Agent
14%
Biopsy Technique
14%
Diabetes
28%
Drug Therapy
14%
Dysbiosis
14%
Glucose Uptake
14%
Gut
14%
Gut Microbiota
14%
Hippuric Acid
14%
Homeostasis
14%
Insulin Resistance
14%
Insulin Sensitivity
42%
Nonalcoholic Fatty Liver
100%
Resistance Index
14%
Rifaximin
100%
Steatosis
14%
Transaminase
14%
Urinary System
28%
Pharmacology, Toxicology and Pharmaceutical Science
Alanine Aminotransferase
42%
Aminotransferase
14%
Antidiabetic Agent
14%
Dysbiosis
14%
Feces microflora
14%
Hippuric Acid
14%
Inflammation
14%
Insulin Resistance
14%
Intestine Flora
14%
Nonalcoholic Fatty Liver
100%
Rifaximin
100%
Steatosis
14%